Important note: Information in this article was accurate in August 2007. The state of the art may have changed since the publication date.
First paediatric fixed dose triple combination (Pedimune) is approved by FDA for use in PEPFAR
HIV Treatment Bulletin - Vol. 8, No. 8/9, August-September 2007
On 13 August 2007, the FDA granted tentative approval for purchase under PEPFAR of Pedimune baby, the paediatric triple fixed-dose combination (FDC) of 3TC, d4T and nevirapine.
This is the first fixed-dose antiretroviral product designed to treat children under the age of 12 years. As with adult FDCs containing nevirapine, paediatric patients can use it twice daily once they have 14 days of lead-in treatment with nevirapine, taken once daily. The tablet can also be dissolved in water for children who cannot swallow pills.
As a result of this approval the FDC will be also included on the list maintained by the WHO prequalification programme.
Source: FDA website.
2007-08-10
IB070808-34
©2007. I-BASE HIV Treatment Bulletin. Permission to reproduce courtesy of HIV i-Base, Third Floor East, Thrale House, 44-46 Southwark Street, London SE1 1UN - T: +44 (0) 20 7407 8488 F: +44 (0) 20 7407 8489
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted grants from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, the National Library of Medicine, and donations from users like you. Always watch for outdated information. This article first appeared in 2007. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2007. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content.